Sionna Therapeutics (SION) Non-Current Assets (2024 - 2026)

Sionna Therapeutics has disclosed Non-Current Assets across 3 years of filings, most recently posting $84.1 million for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $84.1 million, down 12.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $340.9 million (changed N/A YoY), and the FY2025 annual result was $84.5 million, up 143.2% from the prior year.
• Non-Current Assets came in at $84.1 million for Q1 2026 at Sionna Therapeutics, down from $84.5 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $96.0 million in Q1 2025 to a low of $34.8 million in Q4 2024.
• The 3-year median for Non-Current Assets is $84.9 million (2025), against an average of $78.6 million.
• Across the five-year window, Non-Current Assets surged 143.2% in 2025 and dropped 12.41% in 2026, its largest moves.
• Sionna Therapeutics' Non-Current Assets stood at $34.8 million in 2024, then jumped by 143.2% to $84.5 million in 2025, then decreased by 0.54% to $84.1 million in 2026.
• The last three Non-Current Assets figures came in at $84.1 million (Q1 2026), $84.5 million (Q4 2025), and $86.9 million (Q3 2025), per Business Quant data.